Used in the synthesis of modified peptides for pharmaceutical research, particularly in the development of enzyme inhibitors and receptor ligands. The Fmoc group enables solid-phase peptide synthesis by providing orthogonal protection for the amino group, allowing stepwise assembly of peptide chains. The D-configuration and halogenated aromatic side chain enhance metabolic stability and influence peptide conformation, improving binding selectivity and resistance to proteolytic degradation. Commonly applied in creating peptidomimetics for drug discovery, especially in oncology and neuropharmacology where precise molecular targeting is required.